Business Daily from THE HINDU group of publications
Monday, March 31, 2008 ePaper | Mobile/PDA Version


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Subscription

Group Sites

News Update as at 18.00 hrs (IST)


Corporate
Suven Life Sciences gets two product patents in Korea, Mexico

MUMBAI: Suven Life Sciences Ltd has announced that two product patents were granted in Mexico and Korea for two of their new chemical entities (NCEs) for the treatment of disorders associated with neuro-degenerative diseases and these patents are valid u ntil 2023.

The patents are exclusive intellectual property of the company and are achieved through the exclusive internal discovery research efforts. Products out of these inventories which are in Pre-clinical development may be out-licensed at the stage of clinica l phase-I or Phase II stage.

The granted claims of the patents include the class of selective 5-HT compounds discovered by Suven and are being developed as therapeutic agents. The compounds are useful in the treatment of cognitive impairment associated with neuro-degenerative disord ers like attention deficient hyperactivity, Alzheimer's Parkinson, Schizophrenia and Huntington's.

Prev: Sun Pharma launches cancer drug
Next: BHEL wins Rs 550-cr export order


Business Line | NUS Index |


Related Topics
Alliances & Joint Ventures
Announcements
Auditing
Awards & Honours
Bonus Announcements
Company Law
Corporate Bonds
Corporate Disputes
Corporate Governance
Courts/Legal Issues
Diversification
Environment
Human Resources
Interview
IPOs
IPR
Management
Mergers & Acquisitions
New Projects
Open Offers
Outlook
Outsourcing
Overseas Borrowings
Overseas Investments
People
Performance
Preferential Allotments
Private Placement
Regulatory Bodies & Rulings
Research & Development
Restructuring
Rights Issue
Sick Units
Society & Development
Standards & Benchmarks
Taxation
Trade & Labour Unions



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line